Product Images Duloxetine Delayed-release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 63629-1990 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - duloxetine 01

Chemical Structure - duloxetine 01

Figure 1 - duloxetine 02

Figure 1 - duloxetine 02

The text describes a graph showing the proportion of patients with relapse over time from randomization in a clinical trial comparing the effectiveness of a placebo versus Duloxetine delayed-release capsules. The x-axis indicates the time in days, and the y-axis represents the percentage of patients experiencing relapse, ranging from 0% to 10%. It can be observed that the group treated with Duloxetine had a lower proportion of relapse cases compared to the placebo group.*

Figure 2 - duloxetine 03

Figure 2 - duloxetine 03

Figure 3 - duloxetine 04

Figure 3 - duloxetine 04

Figure 4 - duloxetine 05

Figure 4 - duloxetine 05

Figure 5 - duloxetine 06

Figure 5 - duloxetine 06

Not available.*

Figure 6 - duloxetine 07

Figure 6 - duloxetine 07

Figure 8 - duloxetine 08

Figure 8 - duloxetine 08

The text indicates data on percentage of patients improved through a medication called DUL administered once daily. The percentage improvements are not given clearly, but present in the form of scattered numbers. The last line shows the percent improvement in pain from the baseline. However, it is not clear what the baseline value represents. Therefore, the available text provides insufficient information to make a useful description.*

Figure 9 - duloxetine 09

Figure 9 - duloxetine 09

Figure 10 - duloxetine 10

Figure 10 - duloxetine 10

This is a chart that displays the percentage of patients improved with respect to the placebo and a drug called DUL60/120mg taken once daily. The x-axis shows increasing numbers from 0 to 100 in increments of 10, and the y-axis shows the percent improvement in pain from baseline using the BOCF measurement method. The chart shows that the DUL60/120mg drug has a higher percentage of patients experiencing an improvement in pain compared to the placebo.*

Label - lbl636291990

Label - lbl636291990

This is a description of a medication called NILD in capsule form. Each capsule contains Duloxetine Hydrochloride, USP 20 mg. It is advised to keep this medication out of children's reach, store in a tight light-resistant container, and keep it tightly closed. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F). It is dispensed in the form of 90 capsules with NDC code 63629-1990-1 and is prescription-only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.